SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Folgar M)
 

Sökning: WFRF:(Folgar M) > Conjunctival melano...

  • Jain, P (författare)

Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study

  • Artikel/kapitelEngelska2021

Förlag, utgivningsår, omfång ...

  • 2020-09-05
  • BMJ,2021

Nummerbeteckningar

  • LIBRIS-ID:oai:prod.swepub.kib.ki.se:147720734
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:147720734URI
  • https://doi.org/10.1136/bjophthalmol-2020-316293DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • To relate conjunctival melanoma characteristics to local control.MethodsRetrospective, registry-based interventional study with data gathered from 10 ophthalmic oncology centres from 9 countries on 4 continents. Conjunctival melanoma patients diagnosed between January 2001 and December 2013 were enrolled in the study. Primary treatments included local excision, excision with cryotherapy and exenteration. Adjuvant treatments included topical chemotherapy, brachytherapy, proton and external beam radiotherapy (EBRT). Cumulative 5-year and 10-year Kaplan-Meier local recurrence rates were related to clinical and pathological T-categories of the eighth edition of the American Joint Committee on Cancer (AJCC) staging system.Results288 patients had a mean initial age of 59.7±16.8 years. Clinical T-categories (cT) were cT1 (n=218,75.7%), cT2 (n=34, 11.8%), cT3 (n=15, 5.2%), cTx (n=21,7.3%) with no cT4. Primary treatment included local excision (n=161/288, 55.9%) followed by excision biopsy with cryotherapy (n=108/288, 37.5%) and exenteration (n=5/288, 1.7%). Adjuvant therapies included topical mitomycin (n=107/288, 37.1%), plaque-brachytherapy (n=55/288, 19.1%), proton-beam (n=36/288, 13.5%), topical interferon (n=20/288, 6.9%) and EBRT (n=15/288, 5.2%). Secondary exenteration was performed (n=11/283, 3.9%). Local recurrence was noted in 19.1% (median=3.6 years). Cumulative local recurrence was 5.4% (3.2–8.9%), 19.3% (14.4–25.5%) and 36.9% (26.5–49.9%) at 1, 5 and 10 years, respectively. cT3 and cT2 tumors were twice as likely to recur than cT1 tumours, but only cT3 had statistically significantly greater risk of local recurrence than T1 (p=0.013). Factors such as tumour ulceration, plica or caruncle involvement and tumour thickness were not significantly associated with an increased risk of local recurrence.ConclusionThis multicentre international study showed that eighth edition of AJCC tumour staging was related to the risk of local recurrence of conjunctival melanoma after treatment. The 10-year cumulative local recurrence remains high despite current management.

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Finger, PT (författare)
  • Fili, MKarolinska Institutet (författare)
  • Damato, BKarolinska Institutet (författare)
  • Coupland, SE (författare)
  • Heimann, H (författare)
  • Kenawy, N (författare)
  • Brouwer, NJ (författare)
  • Marinkovic, M (författare)
  • Van Duinen, SG (författare)
  • Caujolle, JP (författare)
  • Maschi, C (författare)
  • Seregard, SKarolinska Institutet (författare)
  • Pelayes, D (författare)
  • Folgar, M (författare)
  • Yousef, YA (författare)
  • Krema, H (författare)
  • Gallie, B (författare)
  • Calle-Vasquez, A (författare)
  • Karolinska Institutet (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:The British journal of ophthalmology: BMJ105:10, s. 1358-13641468-20790007-1161

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy